Imexpharm Corporation
↗Cao Lãnh, Vietnam
Imexpharm Corporation is a leading Vietnamese pharmaceutical manufacturer established in 1977. The company specializes in the production, import, export, and distribution of high-quality pharmaceutical products, with a strong emphasis on EU-GMP certified manufacturing facilities. Their portfolio includes antibiotics (oral and injectable), cardiovascular, gastrointestinal, diabetes, and central nervous system medications.
In recent years, the company has undergone significant ownership changes, with Livzon Pharmaceutical Group (via Singapore-based Lian SGP Holding) acquiring a controlling stake, following a transfer from South Korea's SK Group in 2025. Imexpharm is actively expanding its high-tech manufacturing capacity and focusing on specialized therapeutic areas to meet growing domestic and international demand.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$90M-$100M
Founded:1977
Ownership:subsidiary
Status:operating
FUNDING
Total Raised:$36.9M
Investors:Livzon Pharmaceutical Group, SK Group (former)
STOCK
Exchange:Ho Chi Minh Stock Exchange
Ticker:IMP
Market Cap:$0.32B
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Livzon Pharmaceutical Group
Acquired By:Livzon Pharmaceutical Group (via Lian SGP Holding) (2025-05-01)
Subsidiaries:Agimexpharm Pharmaceutical Joint Stock Company
Key Partnerships:Sandoz, Pharmacience Canada, Sanofi-Aventis
COMPETITION
Position:Leader
Competitors:Oncogen, Thai-Pharma, Traphaco, Bidiphar, Pymepharco
LEADERSHIP
Key Executives:
Trần Thị Đào - CEO
Sung Min Woo - Chairperson
Board Members:Sung Min Woo, Trần Thị Đào, Chung Suyong, Han Thi Khanh Vinh, Truong Minh Hung, Hoang Duc Hung
LINKS
Website:imexpharm.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Imexpharm Corporation and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Imexpharm Corporation. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.